数字表型的伦理学:关于阿尔茨海默病,语音和人工智能的考虑
Francesca Rose Dino1,2, Peter Scott Pressman3,4, Kevin Bretonnel Cohen5,6
1Department of Neurology, Behavioral Subsection, University of Colorado Anschutz Medical Campus School of Medicine, Aurora, Colorado, USA.
Journal of medical ethics
|January 31, 2025
概括
人工智能 (AI) 数字表型显示出对诊断神经疾病如阿尔茨海默氏症的前景. 然而,在患者的理解和决策能力方面出现了伦理挑战,需要谨慎的风险减轻策略.
科学领域:
- 神经科学是一个神经科学.
- 计算医学是一种计算医学.
- 生物伦理学生物伦理学
背景情况:
- 由人工智能 (AI) 驱动的数字表型,提供了收集行为数据的新方式.
- 计算语音分析是人工智能驱动的数字表型化的一个关键组成部分.
- 神经系统疾病,如阿尔茨海默病,影响行为和认知,使他们成为数字表型化的潜在目标.
研究的目的:
- 探索基于人工智能的数字表型在神经认知障碍中的诊断潜力.
- 识别和解决与神经疾病中的AI数字表型相关的独特的伦理考虑.
- 提出减轻已识别的伦理风险的策略.
主要方法:
- 审查当前的AI数字表型化应用在神经学.
- 对人工智能在诊断诸如阿尔茨海默氏症之类的疾病时所面临的伦理挑战的分析.
- 讨论道德AI实施的风险减轻策略.
主要成果:
- 人工智能数字表型,特别是语音分析,显示出早期发现阿尔茨海默病的潜力.
- 伦理方面的担忧包括决策能力受损和患者对敏感结果的理解有限.
- 传统的临床评估提供了个性化的信息传递和隐私保护,这与AI复制具有挑战性.
结论:
- 人工智能支持的数字表型为评估神经认知障碍提供了重大机会.
- 解决与患者自主,理解和隐私相关的伦理挑战对于负责任的实施至关重要.
- 制定强有力的风险缓解策略对于在神经学中道德地利用人工智能的好处至关重要.
更多相关视频
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
14.8K
10:28Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
15.1K
相关概念视频
Ethics and Bioethics
1.3K
Ethics is a philosophical study of moral actions. Ethics attempts to determine what is valuable for individuals and society. It examines the rational justification of moral judgments and analyzes what is morally just, fair, and right. Bioethics is a sub-discipline of applied ethics that analyzes the philosophical, social, and legal issues in life sciences and medicine. Ethical theories serve as a foundation for decision-making and represent the viewpoints from which people seek direction. They...
1.3K
Alzheimer's Disease: Overview
437
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
437
Human Genetics
528
Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
The complex relationship between genetics and psychology is observable through common biological components such...
528
Dementia
92
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
92
Ethics in Research
22.9K
Today, scientists agree that good research is ethical in nature and is guided by a basic respect for human dignity and safety. However, this has not always been the case. Modern researchers must demonstrate that the research they perform is ethically sound.
22.9K
Alzheimer's Disease: Treatment
158
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
158
